"Die Medizinische Fakultät Mannheim ist eine von zwei unabhängigen Medizinfakultäten der Ruprecht-Karls-Universität Heidelberg. Gemeinsam mit dem Universitätsklinikum Mannheim bildet sie die Universitätsmedizin in Mannheim. Derzeit sind knapp 1.600 Studierende an der Fakultät eingeschrieben."

During the past decade, Medizinische Fakultat Mannheim der Universitat Heidelberg conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medizinische Fakultat Mannheim der Universitat Heidelberg" #1 sponsor was "Amylyx Pharmaceuticals Inc." with 2 trials, followed by "Clovis Oncology, Inc." with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Astex Pharmaceuticals, Inc." with 1 trials sponsored and "Camurus AB" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinische Fakultat Mannheim der Universitat Heidelberg" #1 collaborator was "Foundation Medicine" with 2 trials as a collaborator, "Covance" with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Medizinische Fakultat Mannheim der Universitat Heidelberg" are "Amyotrophic Lateral Sclerosis" (2 trials), "Metastatic Castration Resistant Prostate Cancer" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Crohn Disease" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Medizinische Fakultat Mannheim der Universitat Heidelberg" in a lesser frequency.

Most popular intervention types in "Medizinische Fakultat Mannheim der Universitat Heidelberg" are "Drug" (10 trials), "Biological" (3 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AMX0035" (2 trials), "Rucaparib" (2 trials), "Abiraterone acetate or Enzalutamide or Docetaxel" (1 trials) and "Anti-human CCL24 monoclonal antibody (CM-101)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medizinische Fakultat Mannheim der Universitat Heidelberg" are 9 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Medizinische Fakultat Mannheim der Universitat Heidelberg". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Medizinische Fakultat Mannheim der Universitat Heidelberg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medizinische Fakultat Mannheim der Universitat Heidelberg, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".